NYSE:GRX - Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund Stock Price, Price Target & More

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "GRX."

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund announced a quarterly dividend on Friday, May 18th. Investors of record on Friday, June 15th will be paid a dividend of $0.13 per share on Friday, June 22nd. This represents a $0.52 dividend on an annualized basis and a yield of 5.03%. The ex-dividend date is Thursday, June 14th. View Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's Dividend History.

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Some companies that are related to Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund include BROOKFIELD Rl A/SHS BEN INT (RA), Voya Prime Rate Trust (PPR), Cohen & Steers Limited Drtn Prfd&Incm Fd (LDP), Pimco Income Strategy Fund II (PFN), TEKLA WORLD HEA/BEN INT (THW), Goldman Sachs MLP Income Opportun Fund (GMZ), Nuveen Global High Income Fund (JGH), Ares Dynamic Credit Allocation Fund (ARDC), AllianceBernstein Natnl Muncpl Incm Fnd. (AFB), Kayne Anderson Energy Total Return Fund, Inc. Common Stock (KYE), Western Asset High Yield Dfnd Opp FI (HYI), Nuveen Enhanced Municipal Value Fund (NEV), Pimco Municipal Income Fund (PMF), 1st Tr Sr FR 20/COM (FIV) and Kayne Anderson Midstream Energy Fd (KMF).

Media stories about GRX stock have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund earned a news sentiment score of 0.07 on Accern's scale. They also gave press coverage about the investment management company an impact score of 45.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Matisse Capital (0.47%), Financial & Investment Management Group Ltd. (0.19%) and Cornerstone Wealth Management LLC (0.04%). Company insiders that own Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock include Jeffrey J Jonas Jr and Kuni Nakamura. View Institutional Ownership Trends for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

GRX stock was sold by a variety of institutional investors in the last quarter, including Matisse Capital. View Insider Buying and Selling for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

GRX stock was acquired by a variety of institutional investors in the last quarter, including Financial & Investment Management Group Ltd. and Cornerstone Wealth Management LLC. Company insiders that have bought Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund stock in the last two years include Jeffrey J Jonas Jr and Kuni Nakamura. View Insider Buying and Selling for Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund.

Shares of GRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of GRX stock can currently be purchased for approximately $10.33.

Gabelli Healthcare & WellnessRx Trust Closed-Ended Fund has a market capitalization of $199.78 million.